In addition, there was positive regulation of IL-1β and IL-18 nine months after ischemia, suggesting that SS-31 reduced CKD by protecting mitochondria and preventing the activation of the inflammasome [51]. The gene discussed is IL1B; the disease is chronic kidney disease.